Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EVEROLIMUS for Transplant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 153 adverse event reports in the FDA FAERS database where EVEROLIMUS was used for Transplant.

Most Reported Side Effects for EVEROLIMUS

Side Effect Reports % Deaths Hosp.
Death 5,090 12.8% 5,065 421
Malignant neoplasm progression 3,789 9.6% 1,120 1,076
Diarrhoea 3,061 7.7% 357 1,273
Fatigue 2,946 7.4% 348 975
Stomatitis 2,692 6.8% 203 621
Nausea 2,079 5.2% 222 880
Dyspnoea 1,925 4.9% 424 1,072
Drug ineffective 1,837 4.6% 251 398
Pyrexia 1,664 4.2% 242 1,072
Decreased appetite 1,633 4.1% 223 682
Rash 1,603 4.0% 127 323
Vomiting 1,575 4.0% 230 862
Malaise 1,545 3.9% 230 674
Weight decreased 1,536 3.9% 230 635
Cough 1,480 3.7% 199 657

Other Indications for EVEROLIMUS

Product used for unknown indication (9,230) Breast cancer (4,442) Breast cancer metastatic (2,751) Renal cancer (1,989) Immunosuppressant drug therapy (1,847) Renal transplant (1,604) Renal cell carcinoma (1,573) Neuroendocrine tumour (1,284) Prophylaxis against transplant rejection (862) Angiomyolipoma (794)

Other Drugs Used for Transplant

TACROLIMUS (840) CYCLOSPORINE (486) MYCOPHENOLATE MOFETIL (391) SIROLIMUS (265) TACROLIMUS\TACROLIMUS ANHYDROUS (235) MYCOPHENOLATE (209) MYCOPHENOLIC ACID (178) MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL (155) DACLIZUMAB (143) MELPHALAN (136)

Related Pages

EVEROLIMUS Full Profile All Transplant Drugs EVEROLIMUS Demographics EVEROLIMUS Timeline